US 10953209
Treating tumors using TTFields combined with a PARP inhibitor
granted A61KA61K31/502A61P
Quick answer
US patent 10953209 (Treating tumors using TTFields combined with a PARP inhibitor) held by The Board of Regents of the University of Texas System expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/502, A61P, A61P35/00